Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Toxoplasmosis Vaccines
Researchers from Scientific Institute of Public Health provide details of new studies and findings in the area of toxoplasmosis vaccines
November 12th, 2008
A new study, 'Protective Th1 immune responses against chronic toxoplasmosis induced by a protein-protein vaccine combination but not by its DNA-protein counterpart,' is now available. "Vaccine-induced protection against toxoplasmosis is correlated with cellular immune responses to Toxoplasma gondii, both in animals and man. The goal of the current study was to evaluate whether the combination of a recombinant protein and a plasmid DNA vaccine could offer an advantage over the protein mixture, and protect outbred mice against infection with T. gondii," scientists in Brussels, Belgium report. "To this purpose, the chimeric protein rEC2, encoding antigenic fragments...
Source: Vaccine Weekly (2008-11-12)
|
